Schayowitz Adam Insider Trades & Stock Holdings
Schayowitz Adam, EVP, Head of R&D at Zymeworks Inc. has 1 Form 4 trade on file since Oct 9, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($357.56K), net -$357.56K. Latest filing: disposed of 13.83K shares of $ZYME on Oct 9, 2026 at $25.85.
- Trades on file
- 1
- Open-market bought
- $0
- Open-market sold
- $357.56K
- Net open-market
- -$357.56K
- Latest filing
- Oct 9, 2026
All insider trades by Schayowitz Adam
| Date | Ticker | Type | Shares | Price | Value | Owned after | ΔOwn | 1W | 1M | 6M | Role | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ZYME | Sell (Open-market sale) | 13.83K | $25.85 | $357.56K | -2.9% | EVP, Head of R&D | Read |
"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.
Stocks Schayowitz Adam traded
Frequently asked questions
Has Schayowitz Adam been buying or selling stock?
Schayowitz Adam has 0 open-market purchases and 1 open-market sale on file, net -$357.56K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.
What was Schayowitz Adam's latest insider trade?
disposed of 13.83K shares of $ZYME on Oct 9, 2026 at $25.85.
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.